Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Ankara Universitesi Eczacilik Fakultesi Dergisi is Scopus-indexed (Q3, CiteScore 1). Published by University of Ankara.
Checked against the index lists dated .
ISSN 1015-3918Verify ISSN ↗2564-6524Verify ISSN ↗
Publisher: University of Ankara
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 140 / 191 | 26th | Q3 |
| Pharmacology | 271 / 328 | 17th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present (also 2014, 1997–2010), best quartile Q3, CiteScore 1.
Ankara Universitesi Eczacilik Fakultesi Dergisi is Q3 in Pharmaceutical Science (rank 140 of 191) and Q4 in Pharmacology (rank 271 of 328), by CiteScore 2025.
Ankara Universitesi Eczacilik Fakultesi Dergisi is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1, quartile Q3, 26th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.176, quartile Q3, with an H-index of 17.
Ankara Universitesi Eczacilik Fakultesi Dergisi is published by University of Ankara. Its print ISSN is 1015-3918 and its online ISSN is 2564-6524.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Ankara Universitesi Eczacilik Fakultesi Dergisi has an h-index of 17 and a 2-year mean of 0.58 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q3. On 2-year citations it ranks #129 of 177 Scopus journals in Pharmaceutical Science.
Ankara Universitesi Eczacilik Fakultesi Dergisi published 78 papers in 2025; its busiest recent year was 2023 with 119. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from Türkiye (79.3%), Kazakhstan (4.7%) and India (4.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.